Back

dr. D. Bogaert

Assistant Professor - medical

  • Infectious Diseases Research 1

dr. D. Bogaert

Fellowship and Awards

  • Honours:

    Senior Scottish Clinical Fellowship award (NRS) (2016)

    Innovational Research Incentives Scheme: Vidi laureate (NWO) (2015)

    Innovational Research Incentives Scheme: Veni laureate (NWO) (2009)

    Ter Meulen Fund Stipends, KNAW (2006/2007)

    Prof. Dr. Burema award for most relevant publication in the field of infectious diseases 2004/2005, The Municipal Health Service Rotterdam and Environs (GGD), The Netherlands

    Investigator award 2004/2005, Erasmus MC-Sophia Children’s award, Rotterdam, The Netherlands

    Young investigator award 2004, Pediatric Association of The Netherlands (NVK), The Netherlands

    Prof. Dr. J.C. Birkenhäger award 2003 for excellence in research and presentation, Erasmus MC, Rotterdam, The Netherlands

    Grants:

    2017. Spain. Ramon Areces Foundation: Personal grant of postdoctoral fellow Dr. Alicia Ruiz for a 2-year postdoc in my group to study mycobiome-microbiome interaction. Stipend

    2017. NIHR.Global health research unit: Collaborator of NIHR RESPIRE Unit, University of Edinburgh. £6.000.000

    2017. NIHR. Global health research unit. Collaborator and Steering Committee member of NIHR MPRU Unit, University College London. £6.000.000

    2016-2012. NRS. SSCF. Hhost-microbiome interactions: identification of ecological drivers that are key to respiratory problems in pre-term born children (Scottish Senior Clinical Fellowship). £800.000

    2015-2019 ZonMW. Vidi grant. Host-microbiome interactions: the key to respiratory health? (Personal career grant) €800.000

    2014-2017. ZonMW. Priority Medicines. Consequences of early-life antibiotic exposure on AMR gene selection: what regimen causes least harm? (PI) €400.000

    2014-2016. Gates Foundation. Effect of live attenuated Influenza vaccines on experimental human pneumococcal carriage.€250.000

    2012-2014. Ministry of economic affaires. TKI grant.“Food for life solutions” (co-applicant). €130.000 (of 1.0 million)

    2011-2014 TI Pharma. Collaboratiive grant. Therapeutic effect of an extensively hydrolyzed infant formula on atopic dermatitis” (participant) €100.000 (of 1.5 million)

    2009-2014. NWO/ZonMW. Top grant. “Dynamics of nasopharyngeal colonization of microflora; the key to respiratory disease?” (PI). €625.000

    2009-2012. NWO. Veni grant.“Nasopharyngeal microbial communities and the effects of vaccination” (Personal career grant). €250.000

    2006-2008. KNAW. Ter Meulen Fund. “Interaction between Streptococcus pneumoniae and the maturing host immune system” (personal career grant). €100.000

    2009-2013. Local hospital fund (based on private donations). Friends of WKZ. Respiratory microbiome development in healthy children in relation to delivery mode €150.000/ Respiratory microbiome development in infants with cystic fibrosis and controls. €240.000

    2012. Local. WKZ. “Leading ladies in science” unrestricted grant. €100.000

Research Output (114)

The UK needs a sustainable strategy for COVID-19

Gurdasani Deepti, Bear Laura, Bogaert Debby, Burgess Rochelle A, Busse Reinhard, Cacciola Roberto, Charpak Yves, Colbourn Tim, Drury John, Friston Karl, Gallo Valentina, Goldman Lynn R, Greenhalgh Trisha, Hyde Zoë, Kuppalli Krutika, Majumder Maimuna S, Martin-Moreno Jose M, McKee Martin, Michie Susan, Mossialos Elias, Nouri Ali, Pagel Christina, Pimenta Dominic, Popescu Saskia, Priesemann Viola, Rasmussen Angela L, Reicher Stephen, Ricciardi Walter, Rice Ken, Silver Joshua, Smith Tara C, Wenham Clare, West Robert, Yamey Gavin, Yates Christian, Ziauddeen Hisham 5 dec 2020, In: The Lancet. 396 , p. 1800-1801 2 p.

Scientific consensus on the COVID-19 pandemic:we need to act now

Alwan Nisreen A, Burgess Rochelle Ann, Ashworth Simon, Beale Rupert, Bhadelia Nahid, Bogaert Debby, Dowd Jennifer, Eckerle Isabella, Goldman Lynn R, Greenhalgh Trisha, Gurdasani Deepti, Hamdy Adam, Hanage William P, Hodcroft Emma B, Hyde Zoë, Kellam Paul, Kelly-Irving Michelle, Krammer Florian, Lipsitch Marc, McNally Alan, McKee Martin, Nouri Ali, Pimenta Dominic, Priesemann Viola, Rutter Harry, Silver Joshua, Sridhar Devi, Swanton Charles, Walensky Rochelle P, Yamey Gavin, Ziauddeen Hisham 31 okt 2020, In: The Lancet. 396 , p. e71-e72

Niche- and Gender-Dependent Immune Reactions in Relation to the Microbiota Profile in Pediatric Patients with Otitis Media with Effusion

Enoksson Frida, Ruiz Rodriguez Alicia, Peno Chikondi, Balcazar Lopez Carlos, Tjernström Fredrik, Bogaert Debby, Hakansson Anders P, Bergenfelz Caroline 18 sep 2020, In: Infection and Immunity. 88

From doctors as patients:a manifesto for tackling persisting symptoms of covid-19

Alwan Nisreen A, Attree Emily, Blair Jennifer Mary, Bogaert Debby, Bowen Mary-Ann, Boyle John, Bradman Madeleine, Briggs Tracy Ann, Burns Sarah, Campion Daniel, Cushing Katherine, Delaney Brendan, Dixon Chris, Dolman Grace E, Dynan Caitriona, Frayling Ian M, Freeman-Romilly Nell, Hammond Iulia, Judge Jenny, Järte Linn, Lokugamage Amali, MacDermott Nathalie, MacKinnon Mairi, Majithia Visita, Northridge Tanya, Powell Laura, Rayner Clare, Read Ginevra, Sahu Ekta, Shand Claudia, Small Amy, Strachan Cara, Suett Jake, Sykes Becky, Taylor Sharon, Thomas Kevin, Thomson Margarita, Wiltshire Alexis, Woods Victoria 15 sep 2020, In: BMJ (Clinical research ed.). 370 , p. m3565

Early Life Microbiota and Respiratory Tract Infections

de Steenhuijsen Piters Wouter A A, Binkowska Justyna, Bogaert Debby 12 aug 2020, In: Cell Host & Microbe. 28 , p. 223-232 10 p.

100 years of influenza research seen through the lens of Covid-19

Bogaert Debby, Dockrell David H jul 2020, In: Mucosal immunology. 13 , p. 561-562 2 p.

Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life:a subanalysis of the MAKI randomised controlled trial

Man Wing Ho, Scheltema Nienke M, Clerc Melanie, van Houten Marlies A, Nibbelke Elisabeth E, Achten Niek B, Arp Kayleigh, Sanders Elisabeth A M, Bont Louis J, Bogaert Debby 20 mrt 2020, In: The Lancet Respiratory Medicine. 8 , p. 1022-1031 10 p.

Development of the gut microbiota in early life:The impact of cystic fibrosis and antibiotic treatment

Kristensen Maartje, Prevaes Sabine M.P.J., Kalkman Gino, Tramper-Stranders Gerdien A., Hasrat Raiza, de Winter- de Groot Karin M., Janssens Hettie M., Tiddens Harm A., van Westreenen Mireille, Sanders Elisabeth A.M., Arets Bert, Keijser Bart, van der Ent Cornelis K., Bogaert Debby 1 jan 2020, In: Journal of Cystic Fibrosis. 19 , p. 553-561 9 p.

Immunoglobulin A deficiency in children, an undervalued clinical issue

Koenen M. H.(Mischa), van Montfrans J. M.(Joris), Sanders E. A.M.(Elisabeth), Bogaert D. (Debby), Verhagen L. M.(Lilly) 1 dec 2019, In: Clinical Immunology. 209

Author Correction:Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life (Nature Communications, (2019), 10, 1, (4997), 10.1038/s41467-019-13014-7)

Reyman Marta, van Houten Marlies A., van Baarle Debbie, Bosch Astrid A.T.M., Man Wing Ho, Chu Mei Ling J.N., Arp Kayleigh, Watson Rebecca L., Sanders Elisabeth A.M., Fuentes Susana, Bogaert Debby 25 nov 2019, In: Nature Communications. 10

All Research Output (114)